Gregory Winter

The Nobel Prize in Chemistry 2018

Speaker Fee Range: Please inquire for fees

Travels From: UK

Gregory Winter is available for virtual keynotes and webinars. Please complete the form or contact one of our agents to inquire about the fees for virtual engagements. Please note: the fee range listed above is for in-person engagements.

Nobel Prize Speaker Gregory Winter
REQUEST AVAILABILITY

Want to book Gregory Winter for your event? Please provide the info below and we’ll get in touch within 24h:

    Gregory Winter

    The Nobel Prize in Chemistry 2018

    Speaker Fee Range: Please inquire for fees

    Travels From: UK

    Gregory Winter is available for virtual keynotes and webinars. Please complete the form or contact one of our agents to inquire about the fees for virtual engagements. Please note: the fee range listed above is for in-person engagements.

    Gregory Winter Speaker Biography

    Science speaker Gregory Winter won the Nobel Prize in Chemistry 2018 with George P. Smith and Frances Arnold. Sir Winter studied Natural Sciences at the University of Cambridge. He then completed his PhD at the LMB, working on the amino acid sequence of tryptophanyl tRNA synthetase from the bacterium Bacillus stearothermophilus. His research career has been based almost entirely at the LMB and the MRC Centre for Protein Engineering (CPE). He became a Programme Leader in 1981, was Joint Head of the PNAC Division from 1994-2006, Deputy Director of the LMB from 2006-2011 and acting Director 2007-2008. He was also Deputy Director of CPE from 1990 until its closure in 2010.

    His main research focus is genetic and protein engineering. In his early research, speaker Gregory Winter was interested in the idea that all antibodies have the same basic structure, with only small changes making them specific for one target. He pioneered techniques in humanised and human therapeutic antibodies, which led to antibody therapies for cancer and diseases such as rheumatoid arthritis and multiple sclerosis. He has established hugely successful spin out companies including: Cambridge Antibody Technology (acquired by AstraZeneca), Domantis (acquired by GlaxoSmithKline) and Bicycle Therapeutics.

    He is a Fellow of Trinity College, Cambridge and was the Master of Trinity from 2012 to 2019. He was elected a member of the European Molecular Biology Organisation in 1987, a Fellow of the Royal Society in 1990 and Fellow of the Academy of Medical Sciences in 2006, as well as being a Fellow or Honorary Fellow of many other professional organisations. He has been awarded numerous prizes and medals, including the 2018 Nobel Prize for Chemistry. He received a Knighthood for services to Molecular Biology in 2004.

    Gregory Winter Keynote Topics

    Sir Greg Winter pioneered techniques that have led to antibody therapies for cancer, and diseases such as rheumatoid arthritis and multiple sclerosis. He has established hugely successful spin out companies, including Cambridge Antibody Technology and Domantis, and continues to develop new types of drugs. His technologies are involved in around 65 per cent of marketed antibody drugs today, including Humira and Herceptin.

    Gregory Winter Speaking Videos

    Sir Gregory Winter: Nobel Lecture in Chemistry 2018
    Sir Gregory Winter - The Science Business and Future of Antibody Pharmaceuticals